ASPI (STOCKS)
ASP Isotopes Inc. Common Stock
$6.800000
+0.360000 (+5.59%)
Prev close: $6.440000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Paul E. Mann
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $842.29M
- Employees
- 136
- P/E (TTM)
- -3.23
- P/B (TTM)
- 2.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
6
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.06 | $-0.39 | +0.3276 | +84.52% |
|
Dec 2025 (Q4)
|
$-0.75 | $-0.13 | -0.6208 | -480.50% |
|
Sep 2025 (Q3)
|
$-0.14 | $-0.10 | -0.0380 | -37.25% |
|
Jun 2025 (Q2)
|
$-1.03 | $-0.11 | -0.9178 | -818.00% |
Financial Statements
| Revenues | $26.93M |
| Benefits Costs and Expenses | $204.69M |
| Cost Of Revenue | $22.18M |
| Costs And Expenses | $204.69M |
| Gross Profit | $4.74M |
| Nonoperating Income/Loss | -$100.92M |
| Operating Expenses | $81.59M |
| Research and Development | $16.09M |
| Other Operating Expenses | $65.50M |
| Operating Income/Loss | -$76.84M |
| Income/Loss From Continuing Operations After Tax | -$178.09M |
| Income/Loss From Continuing Operations Before Tax | -$177.77M |
| Income Tax Expense/Benefit | $321.72K |
| Income Tax Expense/Benefit, Deferred | -$40.00K |
| Net Income/Loss | -$158.50M |
| Net Income/Loss Attributable To Noncontrolling Interest | $15.02M |
| Net Income/Loss Attributable To Parent | -$158.50M |
| Net Income/Loss Available To Common Stockholders, Basic | -$158.50M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.08 |
| Diluted Earnings Per Share | -$2.08 |
| Basic Average Shares | 289,591,033 |
| Diluted Average Shares | 289,591,033 |
| Assets | $587.67M |
| Current Assets | $308.74M |
| Inventory | $1.37M |
| Prepaid Expenses | $8.73M |
| Other Current Assets | $298.64M |
| Noncurrent Assets | $278.93M |
| Fixed Assets | $91.80M |
| Other Non-current Assets | $187.13M |
| Liabilities | $288.65M |
| Current Liabilities | $70.37M |
| Accounts Payable | $6.87M |
| Other Current Liabilities | $63.50M |
| Noncurrent Liabilities | $218.29M |
| Long-term Debt | $58.33M |
| Other Non-current Liabilities | $159.96M |
| Equity | $299.02M |
| Equity Attributable To Noncontrolling Interest | $10.02M |
| Equity Attributable To Parent | $289.00M |
| Liabilities And Equity | $587.67M |
| Net Cash Flow From Operating Activities | -$52.37M |
| Net Cash Flow From Operating Activities, Continuing | -$51.25M |
| Net Cash Flow From Investing Activities | -$205.62M |
| Net Cash Flow From Investing Activities, Continuing | -$205.62M |
| Net Cash Flow From Financing Activities | $414.99M |
| Net Cash Flow From Financing Activities, Continuing | $369.11M |
| Exchange Gains/Losses | -$1.23M |
| Net Cash Flow | $155.78M |
| Net Cash Flow, Continuing | $112.24M |
| Comprehensive Income/Loss | -$160.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $15.36M |
| Comprehensive Income/Loss Attributable To Parent | -$175.64M |
| Other Comprehensive Income/Loss | -$2.80M |